JAK2 and myeloproliferative disorder: Systemic risk factors include inherited thrombophilias such as factor V Leiden, prothrombin 20210A, protein C/S deficiency, antithrombin III deficiency, antiphospholipid syndrome, and JAK2-mutated myeloproliferative disorders [1,8].